ORMP - Oramed Pharmaceuticals Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
No. of Analysts2233
Avg. Estimate-0.15-0.08-0.69-0.72
Low Estimate-0.16-0.14-0.98-0.9
High Estimate-0.14-0.03-0.51-0.59
Year Ago EPS-0.23-0.13-0.82-0.69
Revenue EstimateCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
No. of Analysts2233
Avg. Estimate320k1.82M2.91M2.78M
Low EstimateN/AN/A700kN/A
High Estimate650k3.65M5.62M5.95M
Year Ago SalesN/A681k2.7M2.91M
Sales Growth (year/est)N/A167.30%7.70%-4.50%
Earnings History5/30/20198/30/201911/29/20192/28/2020
EPS Est.-0.23-0.24-0.24-0.17
EPS Actual-0.23-0.13-0.15-0.21
Difference00.110.09-0.04
Surprise %0.00%45.80%37.50%-23.50%
EPS TrendCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.15-0.08-0.69-0.72
7 Days Ago-0.15-0.08-0.69-0.72
30 Days Ago-0.2-0.13-0.82-0.78
60 Days Ago-0.2-0.13-0.85-0.79
90 Days Ago-0.2-0.13-0.79-0.68
EPS RevisionsCurrent Qtr. (May 2020)Next Qtr. (Aug 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesORMPIndustrySectorS&P 500
Current Qtr.34.80%N/AN/A-0.10
Next Qtr.38.50%N/AN/A-0.01
Current Year15.90%N/AN/A-0.05
Next Year-4.30%N/AN/A0.16
Next 5 Years (per annum)N/AN/AN/A0.06
Past 5 Years (per annum)N/AN/AN/AN/A